An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Zuogui Jiangtang Shuxin Formula in Diabetic Cardiomyopathy

References

• Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–638. doi:10.1161/CIRCRESAHA.117.311586
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Zheng H, Yang Z, Xin Z, et al. Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis. Theranostics. 2020;10(25):11737–11753. doi:10.7150/thno.47717
   PubMed Web of Science ®Google Scholar
• Parim B, Sathibabu Uddandrao VV, Saravanan G. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy. Heart Fail Rev. 2019;24(2):279–299. doi:10.1007/s10741-018-9749-1
   PubMed Web of Science ®Google Scholar
• Lorenzo-Almorós A, Cepeda-Rodrigo JM, Lorenzo Ó. Diabetic cardiomyopathy. Rev Clin Esp. 2022;222(2):100–111. doi:10.1016/j.rceng.2019.10.012
   PubMed Web of Science ®Google Scholar
• DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016;65(2):20–29. doi:10.1016/j.metabol.2015.10.014
   PubMed Web of Science ®Google Scholar
• Thomas I, Gregg B. Metformin; a review of its history and future: from lilac to longevity. Pediatr Diabetes. 2017;18(1):10–16. doi:10.1111/pedi.12473
   PubMed Web of Science ®Google Scholar
• Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese Medicine for Cardiovascular Disease: evidence and Potential Mechanisms. J Am Coll Cardiol. 2017;69(24):2952–2966. doi:10.1016/j.jacc.2017.04.041
   PubMed Web of Science ®Google Scholar
• Cheng X, Huang ZD. Effect of Zuogui Jiangtang Shuxin Recipe on glucose-lipid metabolism and inflammatory cytokines in high-fat diet MKR mice. Chin Tradit Herb Drugs. 2011;42(03):546–549.
   Google Scholar
• Cheng X, Wu YJ. Protective effect of Zuogui Jiangtang Shuxin Recipe on myocardial impairment in MKR mice. Chin Tradit Herb Drugs. 2011;42(02):343–345.
   Google Scholar
• Wang KX, Gao Y, Gong WX, et al. A novel strategy for decoding and validating the combination principles of huanglian jiedu decoction from multi-scale perspective. Front Pharmacol. 2020;11:567088. doi:10.3389/fphar.2020.567088
   PubMed Web of Science ®Google Scholar
• Wang K, Tian J, Li Y, et al. Identification of components in citri sarcodactylis fructus from different origins via UPLC-Q-exactive Orbitrap/MS. ACS Omega. 2021;6(26):17045–17057. doi:10.1021/acsomega.1c02124
   PubMed Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.118
   PubMed Web of Science ®Google Scholar
• Fernández AM, Kim JK, Yakar S, et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 2001;15(15):1926–1934. doi:10.1101/gad.908001
   PubMed Web of Science ®Google Scholar
• Nair A, Morsy MA, Jacob S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev Res. 2018;79(8):373–382. doi:10.1002/ddr.21461
   PubMed Web of Science ®Google Scholar
• Carbon S, Douglass E, Good BM. The gene ontology resource: enriching a GOld mine. Nucleic Acids Res. 2021;49(D1):D325–D334. doi:10.1093/nar/gkaa1113
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–462. doi:10.1093/nar/gkv1070
   PubMed Web of Science ®Google Scholar
• Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed Pharmacother. 2017;96:305–312. doi:10.1016/j.biopha.2017.10.001
   PubMed Web of Science ®Google Scholar
• Musolino V, Gliozzi M, Scarano F, et al. Bergamot polyphenols improve dyslipidemia and pathophysiological features in a mouse model of non-alcoholic fatty liver disease. Sci Rep. 2020;10(1):2565. doi:10.1038/s41598-020-59485-3
   PubMed Web of Science ®Google Scholar
• Garcia JP, Santana A, Baruqui DL, Suraci N. The Cardiovascular effects of chocolate. Rev Cardiovasc Med. 2018;19(4):123–127. doi:10.31083/j.rcm.2018.04.3187
   PubMed Web of Science ®Google Scholar
• Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem. 2019;299:125124. doi:10.1016/j.foodchem.2019.125124
   PubMed Web of Science ®Google Scholar
• Yu H, Chen B, Ren Q. Baicalin relieves hypoxia-aroused H9c2 cell apoptosis by activating Nrf2/HO-1-mediated HIF1α/BNIP3 pathway. Artif Cells Nanomed Biotechnol. 2019;47(1):3657–3663. doi:10.1080/21691401.2019.1657879
   PubMed Web of Science ®Google Scholar
• Mesgari-Abbasi M, Valizadeh H, Mirzakhani N, Vahdatpour T. Protective effects of di- and tri-peptides containing proline, glycine, and leucine on liver enzymology and histopathology of diabetic mice. Arch Physiol Biochem. 2022;128(1):59–68. doi:10.1080/13813455.2019.1662453
   PubMed Web of Science ®Google Scholar
• Ramezani Ali Akbari F, Badavi M, Dianat M, Mard SA, Ahangarpour A. Gallic acid improves oxidative stress and inflammation through regulating micrornas expressions in the blood of diabetic rats. Acta Endocrinol. 2019;15(2):187–194. doi:10.4183/aeb.2019.187
   Google Scholar
• Ren Y, Tao S, Zheng S, et al. Salvianolic acid B improves vascular endothelial function in diabetic rats with blood glucose fluctuations via suppression of endothelial cell apoptosis. Eur J Pharmacol. 2016;791:308–315. doi:10.1016/j.ejphar.2016.09.014
   PubMed Web of Science ®Google Scholar
• Runtuwene J, Cheng KC, Asakawa A, et al. Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4. Drug Des Devel Ther. 2016;10:2193–2202. doi:10.2147/DDDT.S108539
   PubMed Web of Science ®Google Scholar
• An T, Zhang J, Lv B, et al. Salvianolic acid B plays an anti-obesity role in high fat diet-induced obese mice by regulating the expression of mRNA, circRNA, and lncRNA. PeerJ. 2019;7:e6506. doi:10.7717/peerj.6506
   PubMed Web of Science ®Google Scholar
• Li L, Li R, Zhu R, et al. Salvianolic acid B prevents body weight gain and regulates gut microbiota and LPS/TLR4 signaling pathway in high-fat diet-induced obese mice. Food Funct. 2020;11(10):8743–8756. doi:10.1039/d0fo01116a
   PubMed Web of Science ®Google Scholar
• Rajesh KG, Suzuki R, Maeda H, Yamamoto M, Yutong X, Sasaguri S. Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway. J Mol Cell Cardiol. 2005;39(5):766–776. doi:10.1016/j.yjmcc.2005.07.014
   PubMed Web of Science ®Google Scholar
• Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, et al. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol. 2008;294(2):H724–735. doi:10.1152/ajpheart.00979.2007
   PubMed Web of Science ®Google Scholar
• Ebner B, Lange SA, Hollenbach D, et al. In situ postconditioning with neuregulin-1β is mediated by a PI3K/Akt-dependent pathway. Can J Cardiol. 2015;31(1):76–83. doi:10.1016/j.cjca.2014.10.035
   PubMed Web of Science ®Google Scholar
• Kim D, Dan HC, Park S, et al. AKT/PKB signaling mechanisms in cancer and chemoresistance. Front Biosci. 2005;10:975–987. doi:10.2741/1592
   PubMed Web of Science ®Google Scholar
• Niu F, Qian K, Qi H, Zhao Y, Jiang Y, Sun M. Antiapoptotic and anti-inflammatory effects of CPCGI in rats with traumatic brain injury. Neuropsychiatr Dis Treat. 2020;16:2975–2987. doi:10.2147/NDT.S281530
   PubMed Web of Science ®Google Scholar
• Opferman JT, Kothari A. Anti-apoptotic BCL-2 family members in development. Cell Death Differ. 2018;25(1):37–45. doi:10.1038/cdd.2017.170
   PubMed Web of Science ®Google Scholar
• Mallipattu SK, Gallagher EJ, LeRoith D, et al. Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus. Am J Physiol Renal Physiol. 2014;306(9):F1008–1017. doi:10.1152/ajprenal.00597.2013
   PubMed Web of Science ®Google Scholar
• Rena G, Lang CC. Repurposing metformin for cardiovascular disease. Circulation. 2018;137(5):422–424. doi:10.1161/CIRCULATIONAHA.117.031735
   PubMed Web of Science ®Google Scholar
• Fung CS, Wan EY, Wong CK, Jiao F, Chan AK. Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients. Cardiovasc Diabetol. 2015;14:137. doi:10.1186/s12933-015-0304-2
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang L, Shi X, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Aging. 2020;12(23):24270–24287. doi:10.18632/aging.202143
   PubMedGoogle Scholar
• Higgins L, Palee S, Chattipakorn SC, Chattipakorn N. Effects of metformin on the heart with ischaemia-reperfusion injury: evidence of its benefits from in vitro, in vivo and clinical reports. Eur J Pharmacol. 2019;858:172489. doi:10.1016/j.ejphar.2019.172489
   PubMed Web of Science ®Google Scholar